.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Timolol - Generic Drug Details

« Back to Dashboard
Timolol is the generic ingredient in eight branded drugs marketed by Akorn, Oak Pharms Inc, Usl Pharma, Apotex Inc, Bausch And Lomb, Merck, Watson Labs, Valeant Pharms Llc, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Alcon Res Ltd, Hi Tech Pharma, Aton, Quantum Pharmics, Fougera, Mylan, and Wockhardt, and is included in forty-five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for timolol. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: timolol

Tradenames:8
Patents:3
Applicants:19
NDAs:45
Drug Master File Entries: see list15
Suppliers / Packagers: see list3
Bulk Api Vendors: see list23
Clinical Trials: see list96
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: timolol

Tentative approvals for TIMOLOL

Applicant Application No. Form Dosage
<disabled><disabled>SOLUTION;OPHTHALMIC0.5%
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982RXYes► subscribe► subscribe
Apotex Inc
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC204936-001Apr 17, 2015RXNo► subscribe► subscribe
Alcon Res Ltd
TIMOLOL MALEATE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC020963-001Oct 21, 1998RXNo6,174,524*PED► subscribeY► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: timolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-001Mar 31, 19955,231,095► subscribe
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-002Mar 31, 19955,231,095► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc